• SI-BONE Inc SIBN.OQ reported a quarterly adjusted loss of 11 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -27 cents. The mean expectation of nine analysts for the quarter was for a loss of 15 cents per share. Wall Street expected results to range from -19 cents to -1 cents per share.

• Revenue rose 26.1% to $49.00 million from a year ago; analysts expected $47.89 million.

• SI-BONE Inc's reported EPS for the quarter was a loss of 11 cents​.

• The company reported a quarterly loss of $4.5 million.

• SI-BONE Inc shares had risen by 27.2% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.3% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for SI-BONE Inc is $25.00

This summary was machine generated from LSEG data February 24 at 10:40 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)